Susan Appt to Selective Estrogen Receptor Modulators
This is a "connection" page, showing publications Susan Appt has written about Selective Estrogen Receptor Modulators.
Connection Strength
0.785
-
Clarkson TB, Ethun KF, Pajewski NM, Golden D, Floyd E, Appt SE. Effects of bazedoxifene, conjugated equine estrogens, and a tissue-selective estrogen complex containing both bazedoxifene and conjugated equine estrogens on cerebral artery atherosclerosis in postmenopausal monkeys. Menopause. 2014 Jan; 21(1):8-14.
Score: 0.460
-
Ethun KF, Wood CE, Cline JM, Register TC, Appt SE, Clarkson TB. Endometrial profile of bazedoxifene acetate alone and in combination with conjugated equine estrogens in a primate model. Menopause. 2013 Jul; 20(7):777-84.
Score: 0.111
-
Clarkson TB, Ethun KF, Chen H, Golden D, Floyd E, Appt SE. Effects of bazedoxifene alone and with conjugated equine estrogens on coronary and peripheral artery atherosclerosis in postmenopausal monkeys. Menopause. 2013 Mar; 20(3):274-81.
Score: 0.108
-
Ethun KF, Wood CE, Register TC, Cline JM, Appt SE, Clarkson TB. Effects of bazedoxifene acetate with and without conjugated equine estrogens on the breast of postmenopausal monkeys. Menopause. 2012 Nov; 19(11):1242-52.
Score: 0.106